Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy.

Nanomaterials (Basel) · 2026 · PMC13304933 · PMID 42347272

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While both formulations demonstrated comparable accumulation in PSMA-negative PC3-Flu tumors, we observed an increased trend of zinc accumulation in PSMA-positive PC3-PIP tumors, though it did not reach statistical significance ( Figure 5 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.